Evidence map›Paper›PMID 26159922›Full record

ArticleBiochemical and biophysical research communications2015

The PGC-1 coactivators promote an anti-inflammatory environment in skeletal muscle in vivo.

Petra Sabine Eisele, Regula Furrer, Markus Beer, Christoph Handschin

Abstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. 5-HTFrontiers in pharmacology · 2022
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Natural products, PGC-1Acta pharmaceutica Sinica. B · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Petra Sabine EiseleBiozentrum, Division of Pharmacology/Neurobiology, University of Basel, CH-4056 Basel, Switzerland; Zurich Center for Integrative Human Physiology, University of Zurich, CH-8057 Zurich, Switzerland.
Regula FurrerBiozentrum, Division of Pharmacology/Neurobiology, University of Basel, CH-4056 Basel, Switzerland.
Markus BeerBiozentrum, Division of Pharmacology/Neurobiology, University of Basel, CH-4056 Basel, Switzerland.
Christoph HandschinBiozentrum, Division of Pharmacology/Neurobiology, University of Basel, CH-4056 Basel, Switzerland; Zurich Center for Integrative Human Physiology, University of Zurich, CH-8057 Zurich, Switzerland. Electronic address: christoph.handschin@unibas.ch.

Funding

European Research Council 616830
6 · The paper itself

Abstract

The peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) is abundantly expressed in trained muscles and regulates muscle adaptation to endurance exercise. Inversely, mice lacking a functional PGC-1α allele in muscle exhibit reduced muscle functionality and increased inflammation. In isolated muscle cells, PGC-1α and the related PGC-1β counteract the induction of inflammation by reducing the activity of the nuclear factor κB (NFκB). We now tested the effects of these metabolic regulators on inflammatory reactions in muscle tissue of control and muscle-specific PGC-1α/-1β transgenic mice in vivo in the basal state as well as after an acute inflammatory insult. Surprisingly, we observed a PGC-1-dependent alteration of the cytokine profile characterized by an increase in anti-inflammatory factors and a strong suppression of the pro-inflammatory interleukin 12 (IL-12). In conclusion, the anti-inflammatory environment in muscle that is promoted by the PGC-1s might contribute to the beneficial effects of these coactivators on muscle function and provides a molecular link underlying the tight mutual regulation of metabolism and inflammation.

Indexed as

AnimalsCytokinesInflammationInflammation MediatorsInterleukin-12LipopolysaccharidesMaleMiceMice, Inbred C57BLMice, TransgenicMuscle, SkeletalNF-kappa BPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaTranscription FactorsTumor Necrosis Factor-alphaCytokinesInflammation MediatorsInterleukin-12LipopolysaccharidesNF-kappa BPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPpargc1a protein, mouseTranscription FactorsTumor Necrosis Factor-alphaInflammationMetabolismMitochondriaPGC-1Skeletal muscle

Identifiers

PMID26159922
PMCPMC4657152

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.